EyePoint Pharmaceuticals Inc
(FRA:PV3B)
€
7.344
-0.288 (-3.77%)
Market Cap: 417.73 Mil
Enterprise Value: 143.51 Mil
PE Ratio: 0
PB Ratio: 1.72
GF Score: 60/100 EyePoint Pharmaceuticals Inc (FRA:PV3B) Transcripts
- Q4 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 07, 2024€24.4 (+5.17%)Earnings
- EyePoint Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- EyePoint Pharmaceuticals Inc Conference call to discuss topline results TranscriptDec 04, 2023
- EyePoint Pharmaceuticals Inc to Host Virtual Key Opinion Leader TranscriptNov 09, 2023
- Q3 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 01, 2023€5.6 (+0.90%)Earnings
- EyePoint Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- EyePoint Pharmaceuticals Inc at HC Wainwright Ophthalmology Virtual Conference - Panel Discussion TranscriptAug 16, 2023
- EyePoint Pharmaceuticals Inc at HC Wainwright Ophthalmology Virtual Conference - On-demand TranscriptAug 16, 2023
- Q2 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 02, 2023€10.9 (-2.68%)Earnings
- EyePoint Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2023€5.8 (-3.33%)Earnings
- EyePoint Pharmaceuticals Inc at Guggenheim Healthy Altitudes Summit TranscriptMar 15, 2023
- Q4 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 02, 2023€2.9 (-7.05%)Earnings
- Q3 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2022€5.5 (+0.92%)Earnings
- Q2 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2022€9.05 (+4.02%)Earnings
- EyePoint Pharmaceuticals Inc Investor Day TranscriptJul 18, 2022
- Q1 2022 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022€11.2 (-0.88%)Earnings
- EyePoint Pharmaceuticals Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- Q4 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 03, 2022€8.75 (-3.31%)Earnings
- EyePoint Pharmaceuticals Inc Phase 1 DAVIO Trial Of EYP-1901 Results Conference Call TranscriptNov 13, 2021
- Q3 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€10.6 (+1.92%)Earnings
- EyePoint Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2021€7.1 (+2.16%)Earnings
- Q1 2021 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€8.7 (-1.14%)Earnings
- Q4 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 04, 2021€9.6 (-4.00%)Earnings
- EyePoint Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- EyePoint Pharmaceuticals Inc to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD TranscriptDec 04, 2020
- Q3 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€3.8 (+23.38%)Earnings
- Q2 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2020€6.06 (-0.98%)Earnings
- Q1 2020 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€8.1 (-6.36%)Earnings
- Q4 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2020€13.1 (-25.14%)Earnings
- Q3 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019€16 (-22.33%)Earnings
- Q2 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptAug 07, 2019€11.03 (+1.75%)Earnings
- Q1 2019 EyePoint Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2019€14.53 (-2.22%)Earnings
- EyePoint Pharmaceuticals Inc Six-Month Transition Period Ended December 31, 2018 Earnings Call TranscriptMar 14, 2019€22.5 (-1.75%)Earnings
- 1